FeaturedUrology
Next-Generation Therapeutic Approaches in Advanced Prostate Cancer: The Role of Darolutamide
Prostate cancer cells rely on testosterone (androgens) for proliferation and survival. Although conventional hormone therapy—comprising anti-androgens and luteinizing hormone-releasing hormone (LHRH) analogs—depletes circulating testosterone levels, aggressive prostate cancer cells can adapt, develop treatment resistance, and continue to proliferate.
